پارس دارو
دپارس | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/08/16 Fiscal Year 2026/03/2012 Month | 2025/07/14 Fiscal Year 2025/03/2012 Month | 2024/07/03 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 103.199 Billion | 157.322 Billion | 221.277 Billion | |
Trade Receivables | 33.063 Trillion | 26.044 Trillion | 14.421 Trillion | |
Prepayments | 1.649 Trillion | 1.265 Trillion | - | |
Orders & Prepayments | - | - | 1.396 Trillion | |
Raw Materials & Packaging Inventory | 3.49 Trillion | 2.742 Trillion | 2.446 Trillion | |
Work-in-Progress Inventory | 132.878 Billion | 379.792 Billion | 644.315 Billion | |
Finished Goods Inventory | 178.332 Billion | 125.766 Billion | 953.32 Billion | |
Spare Parts Inventory | 156.602 Billion | 131.215 Billion | 104.622 Billion | |
Goods in Transit | 145.524 Billion | 630 Million | 2.241 Billion | |
Our Goods on Consignment with Others | 10.176 Billion | 5.691 Billion | 5.691 Billion | |
Other Inventories | 66.677 Billion | - | 79.685 Billion | |
Inventories | 4.629 Trillion | 3.456 Trillion | 4.236 Trillion | |
Total Current Assets | 39.444 Trillion | 30.922 Trillion | 20.275 Trillion | |
Long-Term Investments | - | 4.759 Billion | 4.489 Billion | |
Long-Term Investments in Affiliates | 841.518 Billion | 843.471 Billion | 900.737 Billion | |
Long-Term Trade Receivables | 14.967 Billion | 8.592 Billion | 3.368 Billion | |
Intangible Assets | 39.205 Billion | 47.456 Billion | 44.8 Billion | |
Property, Plant & Equipment | 1.639 Trillion | 950.471 Billion | 442.868 Billion | |
Net Fixed Assets | 1.639 Trillion | 950.471 Billion | 442.868 Billion | |
Total Non-Current Assets | 2.535 Trillion | 1.855 Trillion | 1.396 Trillion | |
Total Assets | 41.979 Trillion | 32.777 Trillion | 21.671 Trillion | |
Trade Payables | 4.971 Trillion | 3.943 Trillion | 2.03 Trillion | |
Advances Received | 423.543 Billion | 203.294 Billion | 4.45 Billion | |
Income Tax Provision | 1.86 Trillion | 1.387 Trillion | 1.269 Trillion | |
Proposed & Payable Dividends | 14.335 Trillion | 8.883 Trillion | 7.009 Trillion | |
Current Borrowings | 1.433 Trillion | 822.093 Billion | 1.806 Trillion | |
Total Current Liabilities | 23.022 Trillion | 15.239 Trillion | 12.119 Trillion | |
Long-Term Borrowings | 800.125 Billion | 5.988 Billion | 9.156 Billion | |
Employee Termination Benefits Provision | 615.74 Billion | 428.848 Billion | 269.138 Billion | |
Total Non-Current Liabilities | 1.416 Trillion | 434.836 Billion | 278.294 Billion | |
Total Liabilities | 24.438 Trillion | 15.673 Trillion | 12.397 Trillion | |
Capital | 2.45 Trillion | 950 Billion | 950 Billion | |
Capital Raise in Progress | - | 1.266 Trillion | - | |
Retained Earnings | 14.903 Trillion | 14.851 Trillion | 8.322 Trillion | |
Legal Reserve | 245 Billion | 95 Billion | 95 Billion | |
Share Premium Reserve | -57.942 Billion | -57.942 Billion | -93.394 Billion | |
Total Equity | 17.54 Trillion | 17.104 Trillion | 9.274 Trillion | |
Total Liabilities & Equity | 41.979 Trillion | 32.777 Trillion | 21.671 Trillion | |
Approved Capital | 2.45 Trillion | 950 Billion | 950 Billion | |
Approved Capital Raise in Progress | - | 1.266 Trillion | - | |
Approved Retained Earnings | 6.904 Trillion | 3.308 Trillion | 3.05 Trillion | |
Approved Legal Reserve | 245 Billion | 95 Billion | 95 Billion | |
Total Approved Equity (at AGM) | 9.599 Trillion | 5.619 Trillion | 4.095 Trillion | |
کالای امانی دیگران نزد ما | -449.28 Billion | - | - | |
Scrap Inventory | - | 70.772 Billion | - |